2023
Black-White differences in uterine cancer symptomatology and stage at diagnosis
Xu X, Chen L, Nunez-Smith M, Clark M, Ferris J, Hershman D, Wright J. Black-White differences in uterine cancer symptomatology and stage at diagnosis. Gynecologic Oncology 2023, 180: 118-125. PMID: 38091770, PMCID: PMC10922746, DOI: 10.1016/j.ygyno.2023.11.029.Peer-Reviewed Original ResearchAdvanced stage diagnosisWhite patientsPostmenopausal bleedingPatient characteristicsEnd Results-Medicare databaseBlack-white differencesBlack-White disparitiesBlack patientsUterine cancerCancer symptomsHigh riskPatientsAdvanced stageSymptomsDiagnosisCancer symptomatologyRegression modelsRiskLarge proportionBleedingHistologyCancerEpidemiologySymptomatologyMonthsTimeliness of diagnostic evaluation for postmenopausal bleeding: A retrospective cohort study using claims data
Xu X, Chen L, Nunez-Smith M, Clark M, Wright J. Timeliness of diagnostic evaluation for postmenopausal bleeding: A retrospective cohort study using claims data. PLOS ONE 2023, 18: e0289692. PMID: 37682914, PMCID: PMC10490884, DOI: 10.1371/journal.pone.0289692.Peer-Reviewed Original ResearchConceptsPostmenopausal bleedingFirst diagnostic procedureDiagnostic evaluationDiagnostic proceduresGynecologic conditionsMedicaid patientsCox proportional hazards modelPrompt diagnostic evaluationRetrospective cohort studyMarketScan Research DatabasesAdditional risk factorsNon-clinical factorsCommon gynecologic conditionProportional hazards modelLower ratesCohort studyMost patientsPatient characteristicsBenign etiologyGynecologic cancerCancer patientsPreventive careUterine cancerInsurance typeRisk factors
2020
Cervical Pemphigus Vulgaris Presenting as Postmenopausal Bleeding
Smith SM, Moscarelli R, Panse G, Parkash V. Cervical Pemphigus Vulgaris Presenting as Postmenopausal Bleeding. International Journal Of Gynecological Pathology 2020, 40: 477-481. PMID: 33323852, DOI: 10.1097/pgp.0000000000000724.Peer-Reviewed Original ResearchConceptsPemphigus vulgarisGenital involvementMucocutaneous blistering diseaseRelapse/recurrenceLong-term survivalCervical involvementPostmenopausal bleedingBullous lesionsCervical originTreatment modalitiesBlistering diseaseUnnecessary interventionsOral cavityPatientsPostmenopausalSymptomsDiseasePemphigusInvolvementVulgarisHysterectomyBleedingCervixPresentingRecurrence
2019
Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy
Desai VB, Wright JD, Gross CP, Lin H, Boscoe FP, Hutchison LM, Schwartz PE, Xu X. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy. American Journal Of Obstetrics And Gynecology 2019, 221: 39.e1-39.e14. PMID: 30853364, PMCID: PMC7006101, DOI: 10.1016/j.ajog.2019.02.051.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAsianBlack or African AmericanComorbidityEndometrial NeoplasmsEndometriosisEthnicityFemaleHispanic or LatinoHumansHysterectomyIncidental FindingsLeiomyomaLeiomyosarcomaMenstruation DisturbancesMetrorrhagiaMiddle AgedObesityPrevalenceRisk AssessmentRisk FactorsSarcomaUnited StatesUterine NeoplasmsUterine ProlapseWhite PeopleYoung AdultConceptsOccult uterine cancerUterine cancerBenign indicationsRisk factorsUterine sarcomaBenign hysterectomyEndometrial carcinomaPredictive valueResearch Cooperative System databaseState cancer registry dataNew York Statewide PlanningHigh negative predictive valueLow positive predictive valueAssociated risk factorsCorpus uteri cancerLarge population-based sampleCancer registry dataPopulation-based sampleAmbulatory surgery centersNegative predictive valuePositive predictive valueRisk prediction modelRace/ethnicityPostmenopausal bleedingPatient characteristics
2017
Ovarian Sertoli-Leydig cell tumors: a single institution experience and review of the literature.
Gressel G, Buza N, Pal L. Ovarian Sertoli-Leydig cell tumors: a single institution experience and review of the literature. European Journal Of Gynaecological Oncology 2017, 38: 214-220. PMID: 29953783.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantDisease-Free SurvivalFemaleHumansHyperandrogenismHysterectomyMiddle AgedNeoadjuvant TherapyNeoplasm GradingOvarian NeoplasmsOvariectomyPostmenopauseRetrospective StudiesSalpingectomySertoli-Leydig Cell TumorConceptsSertoli-Leydig cell tumorOvarian Sertoli-Leydig cell tumorPresent patient populationDisease-free survivalSingle institution experienceTertiary care institutionTime of diagnosisOnset of menopauseRisk of recurrenceSeries of casesAdjuvant chemotherapyMedian followPostmenopausal bleedingPostmenopausal patientsMedian ageMedian intervalClinical presentationDefinitive managementPathological findingsRetrospective reviewInstitution experiencePatient populationTreatment modalitiesCell tumorsTumor grade
2003
Eosinophilia and Uterine Leiomyosarcoma
Pal L, Parkash V, Chambers J. Eosinophilia and Uterine Leiomyosarcoma. Obstetrics And Gynecology 2003, 101: 1130-1132. DOI: 10.1097/00006250-200305001-00030.Peer-Reviewed Original ResearchUterine leiomyosarcomaTissue eosinophiliaOffice-based endometrial biopsyPelvic lymph node dissectionTumor-associated tissue eosinophiliaLow-grade uterine leiomyosarcomaEvidence of leukocytosisMarked eosinophilic infiltratePreoperative laboratory assessmentLymph node dissectionTotal abdominal hysterectomyGynecologic oncology serviceTertiary care hospitalImmediate postoperative periodSpectrum of neoplasmsNormalization of valuesAbsolute eosinophiliaSystemic eosinophiliaSystemic leukocytosisAbdominal hysterectomyBlood eosinophiliaExploratory laparotomyNode dissectionPostmenopausal bleedingPostmenopausal womenEosinophilia and uterine leiomyosarcoma.
Pal L, Parkash V, Chambers JT. Eosinophilia and uterine leiomyosarcoma. Obstetrics And Gynecology 2003, 101: 1130-2. PMID: 12738126, DOI: 10.1016/s0029-7844(02)02338-4.Peer-Reviewed Original ResearchConceptsUterine leiomyosarcomaTissue eosinophiliaOffice-based endometrial biopsyPelvic lymph node dissectionTumor-associated tissue eosinophiliaLow-grade uterine leiomyosarcomaEvidence of leukocytosisMarked eosinophilic infiltratePreoperative laboratory assessmentLymph node dissectionTotal abdominal hysterectomyGynecologic oncology serviceTertiary care hospitalImmediate postoperative periodSpectrum of neoplasmsNormalization of valuesAbsolute eosinophiliaSystemic eosinophiliaSystemic leukocytosisAbdominal hysterectomyBlood eosinophiliaExploratory laparotomyNode dissectionPostmenopausal bleedingPostmenopausal women
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply